Join the Hypoactive Sexual Desire Disorder group to help and get support from people like you.
Hypoactive Sexual Desire Disorder News
Related terms: HSDD, Female Sexual Dysfunction
Many Women With Breast Cancer Struggle With Sexual Health
THURSDAY, Nov. 16, 2023 – For many women with breast cancer, struggles with sexual issues becomes a hidden burden, new research shows. Because most patients don't feel comfortable talking over these...
Rates of Sexual Dysfunction High in Patients With Schizophrenia
FRIDAY, Sept. 15, 2023 – There is a high prevalence of sexual dysfunction among individuals with schizophrenia, according to a review published online Sept. 13 in JAMA Psychiatry. Théo Korchia, ...
Amag Pharmaceuticals Announces FDA Approval of Vyleesi (bremelanotide injection) for Hypoactive Sexual Desire Disorder (HSDD) in Premenopausal Women
WALTHAM, Mass. June 21, 2019 – AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) announced today that the U.S. Food and Drug Administration (FDA) has approved Vyleesi (bremelanotide injection), a melanocortin ...
FDA Orders Important Safety Labeling Changes for Addyi Regarding Alcohol Consumption
April 11, 2019 – The U.S. Food and Drug Administration today issued a safety labeling change order to Sprout Pharmaceuticals for their drug, Addyi (flibanserin), that requires the company to revise...
FDA Approves Addyi (flibanserin) for Hypoactive Sexual Desire Disorder in Premenopausal Women
August 18, 2015 - The U.S. Food and Drug Administration today approved Addyi (flibanserin) to treat acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. Prior to...
Ask a question
To post your own question to this support group, sign in or create an account.